AI for rare diseases: putting tech to work for small populationsWith the 12th annual Rare Disease Day on the horizon, it’s a pertinent time to think about how Share XAI for rare diseases: putting tech to work for small populationshttps://pharmaphorum.com/spotlight/ai-in-pharma-marketing/ai-rare-diseases/
How digital is reversing fortunes in R&DA new report lays out the ways digital transformation could reverse the trend of declining ROI in pharma Share XHow digital is reversing fortunes in R&Dhttps://pharmaphorum.com/views-analysis-digital/digital-reversing-fortunes-rd/
AI-powered study backs anticoagulants for heart failure patients without AFA new study has found that blood thinning drugs improve outcomes for all heart failure patients, regardless of Share XAI-powered study backs anticoagulants for heart failure patients without AFhttps://pharmaphorum.com/news/ai-powered-study-backs-anticoagulants-for-heart-failure-patients-without-af/
Mind the gap: Bridging the divide between digital health potential and realityShould digital health innovators be doing more to ensure healthcare professionals have the knowledge they need to embed Share XMind the gap: Bridging the divide between digital health potential and realityhttps://pharmaphorum.com/views-analysis-digital/mind-the-gap-bridging-the-divide-between-digital-health-potential-and-reality/
50% of biopharma CMOs say they don’t know what customers wantIt’s indisputable that one of the keys to growth is understanding what your customers want and delivering it Share X50% of biopharma CMOs say they don’t know what customers wanthttps://pharmaphorum.com/views-analysis-sales-marketing/50-of-biopharma-cmos-say-they-dont-know-what-customers-want/
Artificial intelligence and the future of rep visitsAs access to healthcare professionals (HCPs) declines, the challenges facing sales representatives continue to increase: less time with Share XArtificial intelligence and the future of rep visitshttps://pharmaphorum.com/views-analysis-digital/artificial-intelligence-and-the-future-of-rep-visits/
Q&A: Medidata’s Christian Hebenstreit on clinical trials trends for 2020We spoke to Christian Hebenstreit, senior VP and general manager, EMEA at Medidata, a Dassault Systèmes company, to Share XQ&A: Medidata’s Christian Hebenstreit on clinical trials trends for 2020https://pharmaphorum.com/r-d/views-analysis-r-d/qa-medidatas-christian-hebenstreit-on-clinical-trials-trends-for-2020/
Could artificial intelligence replace pharma reps?Whether artificial intelligence (AI) could replace reps entirely was the subject of a discussion at this year’s Veeva’s Share XCould artificial intelligence replace pharma reps?https://pharmaphorum.com/views-analysis-digital/could-artificial-intelligence-replace-pharma-reps/
The power of everyday AIEven with discussions about artificial intelligence (AI) becoming part of everyday life, it can sometimes still be difficult Share XThe power of everyday AIhttps://pharmaphorum.com/views-analysis-digital/the-power-of-everyday-ai/
